Skip to main content
Log in

Preventive effect of gastrodin on cognitive decline after cardiac surgery with cardiopulmonary bypass: A double-blind, randomized controlled study

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

Cognitive decline is a common complication after cardiac surgery with cardiopulmonary bypass (CPB), but as such no pharmacological therapy has been shown to be efficacious in preventing the decline. However, gastrodin has been shown to have multi-pharmacological effects on neurological functions. We undertook this study to test the hypothesis that gastrodin would potentially prevent CPB-associated neurocognitive decline. We randomly assigned 200 patients undergoing mitral valve replacement surgery to receive either gastrodin (40 mg/kg) or saline after the induction of anesthesia and subsequently evaluated cognitive function before surgery, at discharge, and at 3rd month after surgery by using a battery of five neurocognitive tests, or adverse effects of gastrodin postoperatively. Neurocognitive decline in postoperative function was defined as a drop of 1 SD or more in the scores on tests of any one of the four domains of cognitive function. Cognitive decline occurred in 9% of the patients in the gastrodin group in contrast to 42% in the control group (P<0.01) at discharge. Cognitive outcome could be determined at 3rd month in 87 patients in the gastrodin group and 89 in the control group. Cognitive decline was detected in 6% in the gastrodin group and 31% in the control group (P<0.01). The incidences of possible adverse effects were similar between two groups. These results indicate that gastrodin is an effective and a safe drug for the prevention of neurocognitive decline in patients undergoing mitral valve replacement surgery with CPB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Newman MF, Kirchner JL, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary artery bypass surgery. N Engl J Med, 2001, 344(6):395–402

    Article  CAS  PubMed  Google Scholar 

  2. Selnes OA, Goldsborough MA, Borowicz LM, et al. Neurobehavioral sequelae of cardiopulmonary bypass. Lancet, 1999,353(9164):1601–1606

    Article  CAS  PubMed  Google Scholar 

  3. Lund C, Hol PK, Lundblad R, et al. Comparison of cerebral embolization during off-pump and on-pump coronary artery bypass surgery. Ann Thorac Surg, 2003, 76(3):765–770

    Article  PubMed  Google Scholar 

  4. Brown WR, Moody DM, Challa VR, et al. Longer duration of cardiopulmonary bypass is associated with greater numbers of cerebral microemboli. Stoke, 2000, 31(3):707–713

    CAS  Google Scholar 

  5. Sato Y, Laskowitz DT, Bennett ER, et al. Differential cerebral gene expression during cardiopulmonary bypass in the rat: evidence for apoptosis? Anesth Analg, 2002,94(6):1389–1394

    Article  CAS  PubMed  Google Scholar 

  6. Siesjö BK, Zhao Q, Pahlmark K, et al. Glutamate, calcium, and free radicals as mediators of ischemic brain damage. Ann Thorac Surg, 1995,59(5):1316–1320

    Article  PubMed  Google Scholar 

  7. Murkin JM. Attenuation of neurologic injury during cardiac surgery. Ann Thorac Surg, 2001,72(5):S1838–S1844

    Article  CAS  PubMed  Google Scholar 

  8. Tseng EE, Brock MV, Kwon CC, et al. Increased intracerebral excitatory amino acids and nitric oxide after hypothermic circulatory arrest. Ann Thorac Surg, 1999, 67(2):371–376

    Article  CAS  PubMed  Google Scholar 

  9. Chakravarthy M, Manjunath V, Javali V, et al. Neurocognitive behavior changes in patients undergoing off pump coronary artery bypass surgery: A prospective observational study. J Anaesth Clin Pharmacol, 2008, 24(1):45–52

    Google Scholar 

  10. Raja PV, Blumenthal JA, Doraiswamy MP. Cognitive deficits following coronary artery bypass grafting: prevalence, prognosis, and therapeutic strategies. CNS Spect, 2004,9(10):763–772

    Google Scholar 

  11. Yu SJ, Kim JR, Lee CK, et al. Gastrodia elata Blume and an active component, p-hydroxybenzyl alcohol reduce focal ischemic brain injury through antioxidant related gene expressions. Biol Pharm Bull, 2005, 28(6):1016–1020

    Article  CAS  PubMed  Google Scholar 

  12. Hsieh CL, Chen CL, Tang NY, et al. Gastrodia elata BL mediates the suppression of nNOS and microglia activation to protect against neuronal damage in kainic acid-treated rats. Am J Chin Med, 2005,33(4):599–611

    Article  PubMed  Google Scholar 

  13. Kim HJ, Lee SR, Moon KD. Ether fraction of methanol extracts of Gastrodia elata, medicinal herb protects against neuronal cell damage after transient global ischemia in gerbils. Phytother Res, 2003,17(8):909–912

    Article  PubMed  Google Scholar 

  14. Kim HJ, Moon KD, Oh SY, et al. Ether fraction of methanol extracts of Gastrodia elata, a traditional medicinal herb, protects against kainic acid-induced neuronal damage in the mouse hippocampus. Neurosci Lett, 2001,314(1–2):65–68

    Article  CAS  PubMed  Google Scholar 

  15. Lee YS, Ha JH, Yong CS, et al. Inhibitory effects of constituents of Gastrodia elata Bl. on glutamate -induced apoptosis in IMR-32 human neuroblastoma cells. Arch Pharm Res, 1999,22(4):404–409

    CAS  Google Scholar 

  16. Huang NK, Lin YL, Cheng JJ, et al. Gastrodia elata prevents rat pheochromocytoma cells from serum-deprived apoptosis: the role of the MAPK family. Life Sci, 2004,75(13):1649–1657

    Article  CAS  PubMed  Google Scholar 

  17. Andersson M, Bergendorff O, Nielsen M, et al. Inhibition of kainic acid binding to glutamate receptors by extracts of Gastrodia. Phytochemistry, 1995,38(4):835–836

    Article  CAS  PubMed  Google Scholar 

  18. Ha JH, Lee DU, Lee JT, et al. 4-Hydroxybenzaldehyde from Gastrodia elata B1 is active in the antioxidation and GABAergic neuromodulation of the rat brain. J Ethnopharmacol, 2000,73(1–2):329–333

    Article  CAS  PubMed  Google Scholar 

  19. Li HB, Chen F. Preparative isolation and purification of gastrodin from the Chinese medicinal plant Gastrodia elata by high-speed counter-current chromatography. J Chromatogr A, 2004,1052(1–2):229–232

    Article  CAS  PubMed  Google Scholar 

  20. Lin LY, Chen YF, Tsai TR, et al. Analysis of brain distribution and biliary excretion of a nutrient supplement, gastrodin, in rat. Anal Chim Acta, 2007,590(2): 173–179

    Article  CAS  PubMed  Google Scholar 

  21. Xu X, Lu Y, Bie X. Protective effects of gastrodin on hypoxia-induced toxicity in primary cultures of rat cortical neurons. Planta Med, 2007,73(7):650–654

    Article  CAS  PubMed  Google Scholar 

  22. Zeng X, Zhang S, Zhang L, et al. A study of the neuroprotective effect of the phenolic glucoside gastrodin during cerebral ischemia in vivo and in vitro. Planta Med, 2006,72(15):1359–1365

    Article  CAS  PubMed  Google Scholar 

  23. Zeng X, Zhang Y, Zhang S, et al. A microdialysis study of effects of gastrodin on neurochemical changes in the ischemic/reperfused rat cerebral hippocampus. Biol Pharm Bull, 2007,30(4):801–804

    Article  CAS  PubMed  Google Scholar 

  24. Hsieh MT, Wu CR, Chen CF. Gastrodin and p-hydroxy benzyl alcohol facilitate memory consolidation and retrieval, but not acquisition, on the passive avoidance task in rats. J Ethnopharmacol, 1997,56(1): 45–54

    Article  CAS  PubMed  Google Scholar 

  25. Zhang S, Wang S, Li Q, et al. Capillary leak syndrome in children with C4A-deficiency undergoing cardiac surgery with cardiopulmonary bypass: a double-blind, randomized controlled study. Lancet, 2005,366(9485): 556–562

    Article  CAS  PubMed  Google Scholar 

  26. Zhang S, Wang S, Yao S. Evidence for development of capillary leak syndrome associated with cardiopulmonary bypass in pediatric patients with the homozygous C4A null phenotype. Anesthesiology, 2004,100(6): 1387–1393

    Article  PubMed  Google Scholar 

  27. Murkin JM, Newman SP, Stump DA, et al. Statement of consensus of neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg, 1995,59(5):1289–1295

    Article  CAS  PubMed  Google Scholar 

  28. Rasmussen LS, Larsen K, Houx P, et al. The assessment of postoperative cognitive function. Acta Anaesthesiol Scand, 2001,45(3):275–289

    Article  CAS  PubMed  Google Scholar 

  29. Newman MF, Grocott HP, Mathew JP, et al. Report of the substudy of assessing the impact of neurocognitive function on quality of life 5 years after cardiac surgery. Stoke, 2001,32(12):2874–2881

    CAS  Google Scholar 

  30. Grocott HP, Mackensen GB, Grigore AM, et al. Postoperative hyperthermia is associated with cognitive dysfunction after coronary artery bypass graft surgery. Stoke, 2002,33(2):537–541

    Google Scholar 

  31. Wang X, Yao S, Kirkpatrick B, et al. Psychopathology and neuropsychological impairment in deficit and nondeficit schizophrenia of Chinese origin. Psychiatry Res, 2008,158(2):195–205

    Article  PubMed  Google Scholar 

  32. Brækken SK, Reinvang I, Russell D, et al. Association between intraoperative cerebral microembolic signals and postoperative neuropsychological deficit: comparison between patients with cardiac valve replacement and patients with coronary artery bypass grafting. J Neurol Neurosurg Psychiatry, 1998,65(4):573–576

    Article  PubMed  Google Scholar 

  33. van Dijk D, Jansen EWL, Hijman R, et al. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery, a randomized trial. JAMA, 2002, 287(11):1405–1412

    Article  PubMed  Google Scholar 

  34. Jonsson H, Johnsson P, Alling C, et al. S100beta after coronary artery surgery: release pattern, source of contamination, and relation to neuropsychological outcome. Ann Thorac Surg, 1999,68(6):2202–2208

    Article  CAS  PubMed  Google Scholar 

  35. Herrmann M, Ebert AD, Galazky I, et al. Neurobehavioral outcome prediction after cardiac surgery: role of neurobiochemical markers of damage to neuronal and glial brain tissue. Stroke, 2000,31(3):645–650

    CAS  PubMed  Google Scholar 

  36. van Dijk D, Spoor M, Hijman R, et al. Cognitive and cardiac outcomes 5 years after off-pump vs on-pump coronary artery bypass graft surgery. JAMA, 2007, 297(7):701–708

    Article  PubMed  Google Scholar 

  37. Newman MF, Croughwell ND, White WD, et al. Pharmacologic electroencephalographic suppression during cardiopulmonary bypass: a comparison of thiopental and isoflurane. Anesth Analg, 1998,86(2):246–251

    Article  CAS  PubMed  Google Scholar 

  38. Selnes OA, Goldsborough MA, Borowicz LM Jr, et al. Determinants of cognitive change after coronary artery bypass surgery: a multifactorial problem. Ann Thorac Surg, 1999,67(6):1669–1676

    Article  CAS  PubMed  Google Scholar 

  39. Jung JW, Yoon BH, Oh HR, et al. Anxiolytic-like effects of Gastrodia elata and its phenolic constituents in mice. Biol Pharm Bull, 2006,29(2):261–265

    Article  CAS  PubMed  Google Scholar 

  40. Gao Z, Tan T, Zhong Y, et al. Study of the mechanism of gastrodin and derivatives of gastrodigenin. Hua Xi Yi Ke Da Xue Xue Bao (Chinese), 1991,22(1):79–82

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shihai Zhang  (张诗海).

Additional information

This study was supported partly by grants from the National Natural Sciences Foundation of China (No. 30271255) and the Natural Sciences Foundation of Hubei Province, China (No. 2006ABB023).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, Z., Ma, P., Xu, Y. et al. Preventive effect of gastrodin on cognitive decline after cardiac surgery with cardiopulmonary bypass: A double-blind, randomized controlled study. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 31, 120–127 (2011). https://doi.org/10.1007/s11596-011-0162-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-011-0162-4

Key words

Navigation